Characterization and predictors of sleep disturbance in patients with relapsed/refractory chronic lymphocytic leukemia (r/r CLL)

被引：0
|
作者：
Westbrook, Travis D.
Maddocks, Kami J.
Andersen, Barbara L.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e18021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18021
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Zanubrutinib vs ibrutinib in relapsed/ refractory chronic lymphocytic leukemia and small lymphocytic lymphoma (R/R CLL/SLL): impact on health-related quality of life (HRQoL)
    Brown, Jennifer
    O'Brien, Susan M.
    Tam, Constantine S.
    Eichhorst, Barbara
    Qiu, Lugui
    Yang, Keri
    Wu, Ken
    Salmi, Tommi
    Barnes, Gisoo
    Lamanna, Nicole
    LEUKEMIA & LYMPHOMA, 2023, 64 : S79 - S80
  • [32] Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)
    Ryan, Christine E.
    Crombie, Jennifer L.
    Tyekucheva, Svitlana
    McDonough, Mikaela M.
    Montegaard, Josie S.
    Kim, Austin, I
    Soumerai, Jacob D.
    Alencar, Alvaro J.
    Bhandari, Shruti
    Fisher, David C.
    Brown, Jennifer R.
    Davids, Matthew S.
    BLOOD, 2022, 140 : 9871 - 9872
  • [33] Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have. Undergone Prior Allogeneic Stem Cell Transplant
    Miklos, David B.
    Coutre, Steven
    O'Brien, Susan
    Byrd, John C.
    Hillmen, Peter
    Brown, Jennifer R.
    Dyer, Martin
    Mato, Anthony R.
    Keating, Michael
    Zhou, Cathy
    Fardis, Maria
    Styles, Lori
    Jaglowski, Samantha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S82 - S83
  • [34] Efficacy and safety of ibrutinib in Chinese patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) and hepatitis B virus reactivation: a post-hoc analysis
    Yang, Shenmiao
    Zhu, Rong
    Feng, Yu
    Zuo, Rui
    Huang, Xiaojun
    LEUKEMIA & LYMPHOMA, 2020, 61 : 102 - 104
  • [35] Efficacy of treatments in children with relapsed/refractory acute lymphocytic leukemia (r/r ALL)
    Martin, Amber L.
    Thomas, Simu K.
    Cota, Mariana
    Hao, Yanni
    Zhang, Younan
    Turner, Monica
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] PHASE I, FIRST-IN-HUMAN TRIAL OF BI 836826 (AN ANTI-CD37 ANTIBODY) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Stilgenbauer, S.
    Schleinitz, T. Aurran
    Hallek, M.
    Lang, F.
    Offner, F.
    Rossi, J. -F.
    Schroyens, W.
    Van Den Neste, E.
    Ysebaert, L.
    Blum, P.
    Hocke, J.
    Kress, U. U.
    Zenz, T.
    HAEMATOLOGICA, 2015, 100 : 225 - 226
  • [37] Prognostic role of beta-2 microglobulin (B2M) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) patients (pts) treated with ibrutinib (ibr).
    Wierda, William G.
    Brown, Jennifer R.
    Stilgenbauer, Stephan
    Coutre, Steven
    Byrd, John C.
    Mato, Anthony R.
    Tam, Constantine
    Barrientos, Jacqueline C.
    Jager, Ulrich
    Devereux, Stephen
    Cymbalista, Florence
    Barr, Paul M.
    Dearden, Claire
    Montillo, Marco
    Moreno, Carol
    Liu, Emily Y.
    Szoke, Anita
    Dean, James P.
    O'Brien, Susan Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Pharmacokinetic, safety and efficacy of high dose simvastatin in refractory and relapsed chronic lymphocytic leukemia (CLL) patients
    Ahmed, Tamer
    Hayslip, John
    Leggas, Markos
    CANCER RESEARCH, 2012, 72
  • [39] A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2269 - 2273
  • [40] Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study
    Van Den Neste, Eric
    Cazin, Bruno
    Janssens, Ann
    Gonzalez-Barca, Eva
    Jose Terol, Maria
    Levy, Vincent
    Perez de Oteyza, Jaime
    Zachee, Pierre
    Saunders, Andrew
    de Frias, Merce
    Campas, Clara
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 581 - 591
12345